Debon Securities released a research report saying that on September 18, 10 departments including the Ministry of Industry and Information Technology and the National Development and Reform Commission announced the “15th Five-Year Plan” for the pharmaceutical industry. The 15th Five-Year Plan is iconic, representing the country's support for cutting-edge innovation and advanced technology; it is recommended to focus on: 1) innovative pharmaceutical companies with FIC/BIC drug research and development capabilities and innovative device companies with R&D capabilities; 2) upstream scientific research enterprises benefiting from AI pharmaceutical technology development and increased R&D expenditure; 3) CXO enterprises and upstream scientific research enterprises with internationalization capabilities that benefit from the continuous increase in new drug research and development and domestic substitution.

Zhitongcaijing · 1d ago
Debon Securities released a research report saying that on September 18, 10 departments including the Ministry of Industry and Information Technology and the National Development and Reform Commission announced the “15th Five-Year Plan” for the pharmaceutical industry. The 15th Five-Year Plan is iconic, representing the country's support for cutting-edge innovation and advanced technology; it is recommended to focus on: 1) innovative pharmaceutical companies with FIC/BIC drug research and development capabilities and innovative device companies with R&D capabilities; 2) upstream scientific research enterprises benefiting from AI pharmaceutical technology development and increased R&D expenditure; 3) CXO enterprises and upstream scientific research enterprises with internationalization capabilities that benefit from the continuous increase in new drug research and development and domestic substitution.